These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18720251)

  • 1. In vitro evaluation of theophylline matrices using xyloglucan.
    Badillo N; Ghaly ES
    Pharm Dev Technol; 2008; 13(6):481-6. PubMed ID: 18720251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic release of theophylline from hydrophilic swellable matrices.
    Vargas CI; Ghaly ES
    Drug Dev Ind Pharm; 1999 Sep; 25(9):1045-50. PubMed ID: 10518245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
    Felician WA; Ghaly ES
    Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrices of water-soluble drug using natural polymer and direct compression method.
    Rosario NL; Ghaly ES
    Drug Dev Ind Pharm; 2002 Sep; 28(8):975-88. PubMed ID: 12378966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits.
    Miyazaki S; Kawasaki N; Endo K; Attwood D
    J Pharm Pharmacol; 2001 Sep; 53(9):1185-91. PubMed ID: 11578100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
    Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
    Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ gelling xyloglucan/pectin formulations for oral sustained drug delivery.
    Itoh K; Yahaba M; Takahashi A; Tsuruya R; Miyazaki S; Dairaku M; Togashi M; Mikami R; Attwood D
    Int J Pharm; 2008 May; 356(1-2):95-101. PubMed ID: 18295417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release behaviour of drugs from tamarind seed polysaccharide tablets.
    Sumathi S; Ray AR
    J Pharm Pharm Sci; 2002; 5(1):12-8. PubMed ID: 12042114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
    Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release characteristics of the matrices prepared from co-spray-dried powders of theophylline and ethylcellulose.
    Kulvanich P; Leesawat P; Patomchaiviwat V
    Drug Dev Ind Pharm; 2002 Jul; 28(6):727-39. PubMed ID: 12149966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug.
    Mamani PL; Ruiz-Caro R; Veiga MD
    Int J Pharm; 2015 Oct; 494(1):235-43. PubMed ID: 26276258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation study and drug release mechanism of a new theophylline sustained-release preparation.
    Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on drug release from aminophylline konjac glucomannan matrix tablet].
    Zhu GQ; Zhang Y; Liu JH
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(21):2236-9. PubMed ID: 18309662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of ethylcellulose as matrices for controlled release drug delivery.
    Quadir MA; Chanda E; Haider SS; Reza MD; Datta BK
    Pak J Pharm Sci; 2005 Apr; 18(2):29-34. PubMed ID: 16431395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
    Ofoefule SI; Chukwu A
    Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.